首页> 外国专利> Methods for regulating hematocrit level in humans, for preparing an erythropoietin product, and for treating anemia in patients at risk of tissue injury, man-made erythropoietin product, and pharmaceutical composition

Methods for regulating hematocrit level in humans, for preparing an erythropoietin product, and for treating anemia in patients at risk of tissue injury, man-made erythropoietin product, and pharmaceutical composition

机译:调节人类血细胞比容水平,制备促红细胞生成素产品和治疗有组织损伤风险的患者贫血的方法,人造促红细胞生成素产品和药物组合物

摘要

"METHODS TO REGULATE HEMATOCYTE LEVEL IN HUMANS, TO PREPARE AN ERYTHROPOIETIN PRODUCT, AND, TO TREAT ANEMIA IN TISSUE INJURY PATIENTS, EYTHROPYETIN PRODUCED BY HEMEM, AND COMPOSITE METHODS an individual while maintaining endogenous tissue protective activities by administering a chemically modified long-lasting erythropoietin-containing pharmaceutical compound. Also disclosed are novel chemically modified long-term erythropoietins, methods of producing chemically modified long-term erythropoietins, and compositions comprising chemically modified long-term erythropoietins.
机译:“调节人类血细胞水平,制备红血球生成素产品以及治疗组织损伤患者贫血的方法,HEMEM生产的眼红素和复合方法,通过维持经长期化学修饰的化学修饰的方法维持个体的内源性组织保护活性的方法还公开了新颖的化学修饰的长期促红细胞生成素,生产化学修饰的长期促红细胞生成素的方法以及包含化学修饰的长期促红细胞生成素的组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号